IDH1 and acute myeloid leukemia: D-2HG production by mutant IDH1 was effectively inhibited in patient-derived AML cells with all reported IDH1R132 mutations ex vivo by BAY-1436032 with an IC50 between 3 and 16 nM [134,135].